Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epidemiology of MDR-TB in Peru (Estudio Epi)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2013 by Harvard University Faculty of Medicine.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborators:
Harvard School of Public Health
Brigham and Women's Hospital
Socios En Salud Sucursal Peru
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Mercedes Becerra, Harvard University Faculty of Medicine
ClinicalTrials.gov Identifier:
NCT00676754
First received: May 8, 2008
Last updated: March 27, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)